Significance of Disseminated Intravascular Coagulation Score in Mortality for Children With Shock

NCT ID: NCT06581172

Last Updated: 2024-09-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-01-01

Study Completion Date

2026-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluates whether the DIC score, as defined according to the International Society of Thrombosis and Hemostasis guidelines is associated with mortality in Children with shock and DIC

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Disseminated intravascular coagulation (DIC) is an acquired syndrome characterized by excessive systemic activation of coagulation, resulting in both hemorrhage and thrombosis. DIC can progress rapidly into lifethreatening multiorgan failure. Under normal hemostatic conditions, clot formation and resolution are tightly regulated. In DIC, dysregulated activation of the coagulation system results in a consumptive coagulopathy and microvascular thrombosis. DIC is always a secondary process caused by a variety of underlying disorders (eg, sepsis, trauma, or malignancy), which can cause endothelial tissue damage and procoagulant exposure .

This activates the coagulation cascade, which promotes fibrin production and deposition and consumption of clotting factors. The subsequent consumption of coagulation factors and platelets, inhibition of natural anticoagulants and fibrinolysis, and fibrin deposition result in the clinical picture of DIC: a bleeding diathesis accompanied by microvascular thrombosis that often leads to end-organ damage . The International Society of Thrombosis and Hemostasis and the Japanese Association for Acute Medicine scoring systems are useful for detection of the DIC in critically ill pediatric patients . The overall incidence of DIC to be 1.2%, using a scoring system comprised of etiologic factors, clinical features, platelet count, prothrombin time, fibrinogen, and fibrin degradation products (FDPs) . The DIC score, easily computed in real-time at the bedside with routine laboratory values, is associated with mortality for children with sepsis andshock.

Diagnosis of DIC through test of the D-dimer. Accordingly, testing for Ddimer or FDPs may be helpful for evulating relationship between DIC score and mortality rate among children with shock .

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Shock, Septic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

D_dimer

DIC score including FDPs,D\_dimer

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All Children with shock and DIC will developed during the period from 1-1-2025 to 31-12-2025

Exclusion Criteria

* Any shock not complicated with DIC
Minimum Eligible Age

1 Year

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nora Abdel Harith Amin

71515,Assiut

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nora AbdelHarithAmin

Role: CONTACT

01024463473

Mahmoud AbdelFattah Ahmed

Role: CONTACT

01003023766

References

Explore related publications, articles, or registry entries linked to this study.

Chanthong S, Choed-Amphai C, Manowong S, Tuntivate P, Tansriratanawong S, Makonkawkeyoon K, Natesirinilkul R. Rotational Thromboelastometry and Clot Waveform Analysis as Point-of-Care Tests for Diagnosis of Disseminated Intravascular Coagulation in Critically Ill Children in Thailand. Pediatr Crit Care Med. 2024 May 1;25(5):e221-e231. doi: 10.1097/PCC.0000000000003452. Epub 2024 Feb 1.

Reference Type BACKGROUND
PMID: 38299935 (View on PubMed)

Infante, J. B., Esteves, G. V., Raposo, J., & de Lacerda, J. F. (2024)

Reference Type BACKGROUND

Kim, T. W., Ko, R. E., Choi, K. H., Chung, C. R., Cho, Y. H., & Yang, J. H. (2024)

Reference Type BACKGROUND

Zafar A, Naeem F, Khalid MZ, Awan S, Riaz MM, Mahmood SBZ. Comparison of five different disseminated intravascular coagulation criteria in predicting mortality in patients with sepsis. PLoS One. 2024 Mar 7;19(3):e0295050. doi: 10.1371/journal.pone.0295050. eCollection 2024.

Reference Type BACKGROUND
PMID: 38452037 (View on PubMed)

Rashad, A. B., Habib, M. S., Saleh, N. Y., & Abo El Fotoh, W. M. (2023)

Reference Type BACKGROUND

Songthawee N, Chavananon S, Sripornsawan P, McNeil E, Chotsampancharoen T. Prevalence and risk factors of disseminated intravascular coagulation in childhood acute lymphoblastic leukemia. Pediatr Res. 2023 Aug;94(2):588-593. doi: 10.1038/s41390-023-02475-8. Epub 2023 Jan 20.

Reference Type BACKGROUND
PMID: 36670158 (View on PubMed)

Zhang, R., Huang, H., Lu, S., Chen, J., Pi, D., Dang, H., ... & Fu, Y. Q. (2024).

Reference Type BACKGROUND

Park, S. J., Oh, S. H., & Jhang, W. K. (2023, November).

Reference Type BACKGROUND

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DIC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.